Font Size: a A A
Keyword [Ugt1a1]
Result: 21 - 40 | Page: 2 of 5
21. Effects Of Yoga Training In The Rehabilitation Treatment Of Chronic Obstructive Pulmonary Disease
22. The Clinical Study Of First And Second Line Treatment Of Irinotecan Combined With Platinum In Small Cell Lung Cancer
23. The Influence Ammonia Cause To Bilirubin Metabolism And The Changes Of Related Enzyme
24. Study For Spectrum Of UGT1A1Variations Associated With Inherited Nonhemolytic Unconjugated Hyperbilirubinemia
25. Study On The Relationship Between UGT1A1and ABCB1Gene Polymorphisms And Irinotecan Toxicity
26. The Association Of UGT1A1~*28、~*6Gene Polymorphism With The Adverse Effects And Efficacy Of Irinotecan
27. Analysis Of SLCO1B1 And UGT1A1 Gene Polymorphisms In Neonatal Hyperbilirubinemia
28. Clinical Study Of The Correlation Between UGT1A1*28 Polymorphism And The Adverse Reaction And The Efficacy Of The Irinotecan Chemotherapy In Patients With Advanced Digestive Tract Malignant Tumors
29. Analysis Of The UGT1A1 SNP With Squamous Carcinoma Larynx Patients
30. Study On UGT1A1 Gene Polymorphism And The Relationship Of Primary Intrahepatic Bile Duct Stones
31. Study Of The Influence Caused By UGT1A1*6 And *28 Gene Polymorphism In Toxicity And Efficacy Of Irinotecan
32. Study On Inhibition Of UGT1A1-Mediated Bilirubin Metabolism By Traditional Chinese Medicine Injection
33. A Research About UGT1A1 Gene Polymorphism Among Unconjugated Hyperbilirubinemia Full-Term Neonates In Chongqing Area
34. The Influence Of The UGT1A1*28 Polymorphism And TCM Syndrome Type On The Adverse Reactions Of Irinotecan
35. Association Of UGT1A1 Polymorphisms With Irinotecan Induced Toxicities In Advanced Colorectal Cancer: A Meta-Analysis In Asians
36. The Correlation Of Individual Response Differences Between The UGT1A1 Gene Polymorphism Of Guangxi Zhuang Metastatic Colorectal Cancer Patients With Irinotecan Treatment
37. Study On The Developmental Expression And Epigenetic Regulation Mechanism Of Human Hepatic UGT1A1
38. Mechanism Of Ginger Xiexin Decoction In Preventing Delayed Diarrhea Caused By Irinotecan
39. A Study On The Relationship Between UGT1A1*28, UGT1A1*6 Polymorphism And The Toxicity Of Irinotecan-based Chemotherapy
40. A Study Of The Correlation Between UGT1A1*28/*6 Gene Polymorphism And The Adverse Reaction And The Efficacy Of Irinotecan-based Chemotherapy In Patients With Advanced Colorectal Cancer
  <<First  <Prev  Next>  Last>>  Jump to